TGF-β, Neuronal Stem Cells and Glioblastoma
Open Access
- 29 August 2005
- journal article
- review article
- Published by Springer Nature in Oncogene
- Vol. 24 (37) , 5722-5730
- https://doi.org/10.1038/sj.onc.1208925
Abstract
Transforming growth factor beta (TGF-β) signaling leads to a number of biological end points involving cell growth, differentiation, and morphogenesis. Typically, the cellular effect accompanies an induction of mesodermal cell fate and inhibition of neural cell differentiation. However, during pathological conditions, these defined effects of TGF-β can be reversed; for example, the growth-inhibitory effect is replaced with its tumor promoting ability. A multitude of factors and cross-signaling pathways have been reported to be involved in modulating the dual effects of TGF-β. In this review, we focus on the potential role of TGF-β signal transduction during development of neural progenitor cells and its relation to glioblastoma development from neural stem cells.Keywords
This publication has 118 references indexed in Scilit:
- Bone Morphogenetic ProteinsGrowth Factors, 2004
- Proteasome inhibitor PS-341 causes cell growth arrest and apoptosis in human glioblastoma multiforme (GBM)Oncogene, 2004
- Calcineurin initiates smooth muscle differentiation in neural crest stem cellsThe Journal of cell biology, 2004
- Smad-dependent and Smad-independent pathways in TGF-β family signallingNature, 2003
- Neural induction, the default model and embryonic stem cellsNature Reviews Neuroscience, 2002
- Mammalian Neural Stem CellsScience, 2000
- Elf3 encodes a novel 200-kD β-spectrin: role in liver developmentOncogene, 1999
- Enhanced expression of transforming growth factor‐β and its type‐I and type‐II receptors in human glioblastomaInternational Journal of Cancer, 1995
- Nestin mRNA expression correlates with the central nervous system progenitor cell state in many, but not all, regions of developing central nervous systemDevelopmental Brain Research, 1995
- Deletion-mutant epidermal growth factor receptor in human gliomas: Effect of type II mutation on receptor functionBiochemical and Biophysical Research Communications, 1991